[go: up one dir, main page]

JPH11508566A - リファブチンを含む抗細菌相乗性組成物 - Google Patents

リファブチンを含む抗細菌相乗性組成物

Info

Publication number
JPH11508566A
JPH11508566A JP9504744A JP50474497A JPH11508566A JP H11508566 A JPH11508566 A JP H11508566A JP 9504744 A JP9504744 A JP 9504744A JP 50474497 A JP50474497 A JP 50474497A JP H11508566 A JPH11508566 A JP H11508566A
Authority
JP
Japan
Prior art keywords
helicobacter pylori
rifabutin
pharmaceutical composition
bismuth
proton pump
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9504744A
Other languages
English (en)
Japanese (ja)
Inventor
ロツシ，ロザリア
ヤベス，ダニエラ
カステラーニ，パオラ
Original Assignee
フアルマシア・エ・アツプジヨン・エツセ・ピー・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フアルマシア・エ・アツプジヨン・エツセ・ピー・アー filed Critical フアルマシア・エ・アツプジヨン・エツセ・ピー・アー
Publication of JPH11508566A publication Critical patent/JPH11508566A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP9504744A 1995-07-04 1996-06-07 リファブチンを含む抗細菌相乗性組成物 Pending JPH11508566A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9513551.3A GB9513551D0 (en) 1995-07-04 1995-07-04 Anti-bacterial synergistic composition
GB9513551.3 1995-07-04
PCT/EP1996/002493 WO1997002039A1 (fr) 1995-07-04 1996-06-07 Composition synergique antibacterienne a base de rifabutine

Publications (1)

Publication Number Publication Date
JPH11508566A true JPH11508566A (ja) 1999-07-27

Family

ID=10777071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9504744A Pending JPH11508566A (ja) 1995-07-04 1996-06-07 リファブチンを含む抗細菌相乗性組成物

Country Status (4)

Country Link
EP (1) EP0836477A1 (fr)
JP (1) JPH11508566A (fr)
GB (1) GB9513551D0 (fr)
WO (1) WO1997002039A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
DE69829905T2 (de) * 1997-02-28 2006-03-09 Kaneka Corp. Heilmittel für durch Helicobacter verursachte Krankheit
WO1999043327A1 (fr) 1998-02-24 1999-09-02 Kaneka Corporation Compositions antimicrobiennes a effet synergique, medicaments et remedes pour maladies digestives contenant ces compositions, leur procede de production et preparations associees
AUPP325398A0 (en) * 1998-04-30 1998-05-21 Borody, Thomas J. Improved method for eradicating h. pylori
AU762890B2 (en) * 1998-04-30 2003-07-10 Red Hill Biopharma Ltd. Improved method for eradication of Helicobacter Pylori
AU3003701A (en) * 1999-11-19 2001-05-30 Axxima Pharmaceuticals Ag Inhibitors of helicobacter pylori induced gastrointestinal diseases
US6849409B2 (en) 2000-10-16 2005-02-01 Axxima Pharmaceuticals Ag Cellular kinases involved in Cytomegalovirus infection and their inhibition
RU2320337C1 (ru) * 2006-06-09 2008-03-27 Федеральное государственное унитарное предприятие "Государственный научный центр по антибиотикам" Способ получения антимикробной композиции с рифабутином
RU2327457C1 (ru) * 2007-06-26 2008-06-27 Автономная некоммерческая организация "Институт молекулярной диагностики" (АНО "ИнМоДи") Лекарственное средство на основе рифабутина, препарат противомикробного действия, содержащий наночастицы, и способ его получения

Also Published As

Publication number Publication date
EP0836477A1 (fr) 1998-04-22
GB9513551D0 (en) 1995-09-06
WO1997002039A1 (fr) 1997-01-23

Similar Documents

Publication Publication Date Title
KR960016582B1 (ko) 위장장해의 치료 및 예방용 약제학적 조성물
AU669903B2 (en) Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
KR970007188B1 (ko) 위장장해 치료 조성물
CA2412795A1 (fr) Ameliorations apportees a des encapsulations de camptothecines dans des liposomes et applications
JP2001526179A (ja) 金属／チオール殺生剤
KR100257367B1 (ko) 위장관 질환 치료용 약제
CA2453263A1 (fr) Compositions pharmaceutiques contenant de la terbinafine et utilisation desdites compositions
JPH11508566A (ja) リファブチンを含む抗細菌相乗性組成物
EP0544760B1 (fr) Compositions pharmaceutiques contenant du 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyle) methylsulfinyle]benzimidazole et un agent anti-helicobacter pour le traitement des troubles gastro-intestinaux
US6426369B1 (en) Oxethazaine as antimicrobial agent
JPH07242560A (ja) 抗菌剤
WO1996019220A1 (fr) Produit composite comprenant de la nitazoxanide et un agent antiulcereux
JP2005213244A (ja) 下痢型過敏性腸症候群治療剤
KR100572090B1 (ko) 상승작용이 있는 항균제 조성물, 그것을 함유하는 의약 및 소화기질환 치료제, 그들의 제조 방법, 및 그에 관련된 제제
JPH01221316A (ja) 脳循環代謝改善剤
JPH0769888A (ja) 抗菌剤
CA2207028A1 (fr) Trousse pour cycle de traitement de l'osteoporose
JPH10158172A (ja) 肝性脳症治療剤又は肝性脳症予防剤
JP2000080031A (ja) 抗菌剤
IE950090A1 (en) Pharmaceutical composition
JPH0899808A (ja) 抗菌剤
IE950954A1 (en) A combination product.
WO2003032979A1 (fr) Compositions induisant une differenciation de cellules malignes et leur utilisation
JPH11246401A (ja) ヘリコバクターピロリ感染症治療剤